N-glycans are commonly found on various glycoproteins. While peptide N-glycosidase from Flavobacterium meningosepticum (PNGase F) is widely used to release virtually all types of N-glycans under denaturing conditions, endo-beta -N-acetylglucosaminidases from the same bacterial species can be used under native conditions to specifically release particular types of N-glycans (1, 2). Because these glycosidases hydrolyze the chitobiose core of N-glycans, the released glycan products will contain one GlcNAc residue at their reducing ends with the other GlcNAc residue remaining attached to the asparagine residue on the glycoproteins. Endo F3 hydrolyzes bi- and triantennary N-glycans (3). In general, this enzyme is more efficient on core fucosylated N-glycans increasing activity up to 400-fold with biantennary structures (4). It also cleaves fucosylated trimannosyl core structures.
Recombinant F. meningosepticum Endo F3 Protein, CF
R&D Systems | Catalog # 5548-GH
Loading...
Key Product Details
- R&D Systems E. coli-derived Recombinant F. meningosepticum Endo F3 Protein (5548-GH)
- Quality control testing to verify active proteins with lot specific assays by in-house scientists
- All R&D Systems proteins are covered with a 100% guarantee
Source
E. coli
Accession Number
Applications
Enzyme Activity
Loading...
Product Specifications
Source
E. coli-derived f. meningosepticum Endo-beta-N-acetylglucosaminidase F3/Endo F3 protein
Ala44-Asn329, with an N-terminal Met and 6-His tag
Ala44-Asn329, with an N-terminal Met and 6-His tag
Purity
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Endotoxin Level
<1.0 EU per 1 μg of the protein by the LAL method.
N-terminal Sequence Analysis
Met
Predicted Molecular Mass
32 kDa
SDS-PAGE
30 kDa, reducing conditions
Activity
Measured by its ability to deglycosylate TSLP under native conditions.
The DC50 is <12 ng. The DC50 is defined as the amount of enzyme required to remove 50% of glycan on 1 μg of recombinant mouse TSLP in 30 minutes at 37 °C.. Use of Recombinant F. meningosepticum Endo‑ beta ‑N‑acetylglucosaminidase F3/Endo F3 in the delycoslyation of other substrates may require alternative conditions for optimal performance.
The DC50 is <12 ng. The DC50 is defined as the amount of enzyme required to remove 50% of glycan on 1 μg of recombinant mouse TSLP in 30 minutes at 37 °C.. Use of Recombinant F. meningosepticum Endo‑ beta ‑N‑acetylglucosaminidase F3/Endo F3 in the delycoslyation of other substrates may require alternative conditions for optimal performance.
Formulation, Preparation, and Storage
5548-GH
| Formulation | Supplied as a 0.2 μm filtered solution in Tris, NaCl and EDTA. |
| Shipping | The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: Endo-beta-N-acetylglucosaminidase F3/Endo F3
References
- Maley, F. et al. (1989) Anal. Biochem. 180:195.
- Tarentino, A.L. et al. (1985) Biochemistry 24:4665.
- Tarentino, A.L. et al. (1993) J. Biol. Chem. 268: 9702.
- Tarentino, A.L. and Plummer, T.H. Jr. (1994) Glycobiology 4:771.
Alternate Names
Endo F3, EndobetaNacetylglucosaminidase F3
UniProt
Additional Endo-beta-N-acetylglucosaminidase F3/Endo F3 Products
Product Documents for Recombinant F. meningosepticum Endo F3 Protein, CF
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Note: Certificate of Analysis not available for kit components.
Product Specific Notices for Recombinant F. meningosepticum Endo F3 Protein, CF
For research use only
Related Research Areas
Customer Reviews for Recombinant F. meningosepticum Endo F3 Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant F. meningosepticum Endo F3 Protein, CF and earn rewards!
Have you used Recombinant F. meningosepticum Endo F3 Protein, CF?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
Protocols
View specific protocols for Recombinant F. meningosepticum Endo F3 Protein, CF (5548-GH):
Materials
- Assay Buffer: 50 mM NaOAc, pH 4.5
- Recombinant F. meningosepticum Endo F3 (rFmEndo F3) (Catalog # 5548-GH)
- Substrate: Recombinant Mouse TSLP (Catalog # 555-TSB)
- 15% SDS-PAGE gel
- Reducing SDS-PAGE gel loading buffer (≥3X concentration)
- Silver Staining reagents
- BioRad GS-800 densitometer (or equivalent)
- Dilute rFmEndo F3 to 5, 2.5, 1.25, 0.625. 0.313, 0.156, 0.078 μg/mL in Assay Buffer.
- Dilute Substrate to 100 μg/mL in Assay Buffer.
- Combine 10 μL rFmEndo F3 at each dilution with 10 μL of 100 μg/mL Substrate. Include a control containing 10 μL Assay Buffer and 10 μL of 100 μg/mL Substrate.
- Incubate the reaction and control at 37 °C for 30 minutes.
- Add 10 μL of reducing gel buffer to each reaction. Boil sample at 100 °C for 3 to 5 minutes before loading to gel.
- Load all of the sample (30 μL) per lane on a 15% gel. As a staining development control load 25 ng BSA.
- Perform electrophoresis.
- Stain gel with silver stain, stop stain development when 25 ng BSA becomes visible.
- Analyze % deglycosylation by densitometry.
- Determine the DC50 for rFmEndoF3 by plotting % Substrate deglycosylated vs. amount with 4-PL fitting.
Per Lane:
- rFmEndo F3: 50, 25, 12.5, 6.25, 3.13, 1.56, 0.78 ng
- Substrate: 1 μg
Loading...